Previous studies showed that total or near-total loss of IL-1 or of its receptor IL-1RI (i.e., of IL-1RI signaling) led to decreased plaque formation, but with the additional problem of increased vulnerability to rupture of the plaques that did form (Figure 1 ). This creates an "out of the frying pan, into the fire" situation; fewer plaques is not an optimal outcome if those remaining plaques are more likely to have devastating consequences. This is where understanding the system in its entirety has great therapeutic benefit. By going beyond simplistic thinking such as "IL-1RI
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signaling is pro-atherosclerotic, therefore we should eliminate that signaling," targeting TILRR provides an opportunity to take a middle ground; IL-1RI signaling is diminished but not eliminated. This also leads to a middle ground in the tissue-level effects, with twin therapeutic consequences: eliminate as many plaques Science author instructions page. Because all the molecules are being tracked, they can also be summed across the cell space to give a total level that can be validated against comparable experimental measurements. Unlike some ABM approaches, the molecular level that the investigators used enabled them to incorporate detailed biophysics, making these models highly mechanistic, not phenomenological.
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Why an ABM rather than a deterministic ordinary Figure 1G to Supplemental Figure 3A) . The model also predicted that TILRR inhibition would decrease inflammatory gene expression, and this was validated in mice (compare experimental results in Figures 1H and 1I and Online Figure 4 to the model results of Online Figure 3B ). Mac Gabhann However, the real insight here is that by targeting TILRR, and thus using a reduction in IL-1RI signaling rather than an elimination of that signaling, the inflammatory response is returned to a more intermediate state (Figure 1) , perhaps closer in character to the absence of injury (recall that in the absence of injury, TILRR expression is lower). In this scenario, plaques are reduced but not eliminated; however, the increased collagen and smooth muscle cell content suggests the plaques are more stable than when IL-1RI is eliminated ( Figure 1 ).
In closing, although much research into signaling has focused on regulation downstream, Smith et al. 
